FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38240211000001100: Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Apr 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
393981000001119 Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
393991000001117 Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Is a Lisoretic true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Lisinopril true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has AMP True Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start